Monday, July 21, 2014

Amgen Foundation Grants $25K to a Colorado STEM Education program

Colorado BioScience Association is honored to announce the Amgen Foundation’s grant of $25,000 to the Colorado BioScience Institute in support of the Research Experience for Teachers (RET) program in Colorado’s science classrooms.

The RET program is an intensive, 4 week, hands-on program for 7th-12th grade teachers. This inaugural year, four teachers were selected to participate. The RET program places teachers in local life science companies to provide them with hands-on lab experience to bridge real-world skills to back the classroom.

The goal is to help build long-term collaborative partnerships between, industry scientists, and the local university research community by involving the teachers in real bioscience research and helping them translate their research experiences and new knowledge into classroom activities.
 
2014 RET Hosting Companies:
 
Biodesix, Inc., Aurora, Boulder Molecular diagnostics advancing personalized medicine www.biodesix.com
 
iC42 Clinical Research & Development, Aurora Contract research services for integrated solutions to systems biology www.bioanalytics.us
 
Sharklet Technologies, Inc., Aurora Engineers surface technologies (Sharklet™) that controls the growth of dangerous bacteria www.sharklet.com 
 
Surefire Medical Inc., Westminster Developing a novel infusion system for the interventional radiology market www.surefiremedical.com

The Amgen Foundation seeks to advance science education, improve patient access to quality care, and strengthen the communities where Amgen staff members live and work. To date, the Foundation has donated more than $200 million in grants to nonprofit organizations throughout the United States, Puerto Rico and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally. For more information, visit http://www.amgen.com/citizenship/overview.html and follow us on http://www.twitter.com/AmgenFoundation.
 
Link to the Business Wire
 
Link to the PitchEngine Social Media Release

Tuesday, July 15, 2014

DBJ: "Med devices drive Colorado bioscience industry"

Quoting from the July 4th posting:

"Colorado’s bioscience industry has grown in recent years on the strength of its medical device companies, its medical labs and specialized medical distribution while other niches and the industry nationwide haven’t fared as well.

Colorado bucked the national trend of declining employment in life sciences and actually expanded payrolls 11 percent, according to a 2014 biennial study of U.S. life sciences published by the industry association BIO and the Battelle life-science consulting group."

Link to the Denver Business Journal

DBJ: 'Colorado gears up advanced-industry angel investor tax credits'

Quoting from the July 11th posting:

"Angel investors in advanced-industries companies are being advised to hurry up and wait as the Colorado Office of Economic Development and International Trade prepares applications for them to get newly created tax credits.'
 
Link to the Denver Business Journal

MarketWatch: 'GlobeImmune Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Overallotment Option'

Quoting from the July 8th posting:

LOUISVILLE, Colo. -- "GlobeImmune, Inc., today announced the closing of its previously announced initial public offering of 1,725,000 shares of its common stock at a price to the public of $10.00 per share, which includes 225,000 shares of common stock sold pursuant to the full exercise of the underwriter's overallotment option. The gross proceeds to GlobeImmune from the initial public offering were $17,250,000, before deducting underwriting discounts and commissions and other offering expenses. Shares of GlobeImmune, Inc. trade on the NASDAQ Capital Market under the ticker symbol 'GBIM.'"
 
Link to the posting

Coverage: Colorado BioScience Association Welcomes the U.S. Patent and Trademark Office ‘Rocky Mountain Regional Satellite Office’ to Denver








Link to CNBC.com












Link to MetroDenver.org












Link to Denver Press Grab







Link to Yahoo! Finance







Link to BioSpace







Link to PharmiWeb

Monday, July 7, 2014

New Issue: Bioscience Colorado Magazine 2014-15 Article Overview

Make sure to check out these "great reads" -- and save the new directory for future use.

The complete flip book of the issue can be found online at: http://www.cobioscience.com/magazine2014flip-book/

Articles - Direct Links:

Mobile Health in Colorado: Where “Big Data” Sparks Big Ideas 
  
Biodesix Harnesses Machine Learning and Analytics to Tackle Multivariate Diagnostics 
  
Bioscience in Colorado Continues to Shine with U.S. Senator Michael Bennet 
  
Colorado Life Science Assets: A Sophisticated Repertoire of Clinical-Stage Therapeutic, Device and Diagnostic Products 
  
U.S. Hub: Colorado Is Where Drug, Device and Therapy Intersect 
  
Boettcher Investigators: Webb-Waring Biomedical Research Program 
  
Found in Translation: Rocky Mountain Lions Eye Institute Translational Research Programs Focus on Innovative Treatment of Eye Diseases 
  
Tech Transfer Offices Connect the Dots between Research and the Marketplace, Stimulate State’s Economy 
  
Colorado Bioscience Industry by the Numbers: Financing and Acquisitions 
  
Colorado Bioscience Grant Programs: Innovation Engines 
  
Colorado Bioscience Industry Directory – updated company information – great to keep on file 

Bioscience Colorado magazine is an integral part of the Association’s mission to support the Colorado bioscience community through advocacy, resources and advancement of opportunities for collaboration. It reaches thousands of bioscience, economic development, legislative, university and industry leaders. Colorado’s bioscience assets are also valuable. Device, diagnostic and therapeutic products created here have a significant economic impact—27,000 in total workforce— translating to over $10 billion in the State’s economy each year. In addition, over 60 acquisitions, financings and grants, totaling over $4 billion, were reported within the 2013 calendar year, further developing the industry’s ecosystem.

Download the new magazine pdf at: http://www.cobioscience.com/Magazine%202014/CBSA_magazine_061314-lowres.pdf

Monday, June 30, 2014

Colorado BioScience Association Welcomes the U.S. Patent and Trademark Office ‘Rocky Mountain Regional Satellite Office’ to Denver

Colorado BioScience Association (CBSA) is honored to welcome the United States Patent and Trademark Office (USPTO) Rocky Mountain Regional Satellite Office and Russell Slifer, its new director, to Denver at today’s historic grand opening. The announcement is made by CBSA President and CEO April Giles, who says, “Bioscience companies in Colorado depend on access to a high quality, efficient patent office; and having patent agents right in our back yard will provide for a better interface, as well as efficient and engaged interactions, in the future.” 

Director Slifer, an intellectual property lawyer, has served as chief patent counsel for Boise, Idaho-based Micron Technology for the past eight years. He also was a design engineer for Honeywell and spent more than nine years in private legal practice in Minnesota helping high-technology clients.

As background, in September 2011, U.S. Senators Mark Udall and Michael Bennet worked to pass the America Invents Act, which allowed for the creation of three new satellite offices for the USPTO. This effort in turn led to the establishment of the Denver office, which according to Giles, should make the patent process more effective and affordable for smaller entities in the region; relieve the logjam of patents awaiting approval; and, result in patent litigation being less imposing and more predictable.
 
  Link to the Business Wire Newswire
 
Link to the PitchEngine Social Media Release